Effect of NBS1 gene polymorphism on the risk of cervix carcinoma in a northern Indian population

International Journal of Biological Markers

Volumn 23, Issue 3, 2008, Pages 133-139

  Sobti, Ranbir Chander ^a   Shekari, M ^a   Kordi Tamandani, D M ^a   Kaur, P ^a   Suri, V ^b   Huria, A ^c  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Cervix cancer; NBS1; Oral contraceptives; Polymorphism; Smoking

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; NIBRIN; ORAL CONTRACEPTIVE AGENT; CELL CYCLE PROTEIN; NBN PROTEIN, HUMAN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; INDIAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PASSIVE SMOKING; UTERINE CERVIX CARCINOMA; CASE CONTROL STUDY; ETHNOLOGY; GENETICS; INDIA; MIDDLE AGED; PATHOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SMOKING; UTERINE CERVIX TUMOR;

ADULT; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CONTRACEPTIVES, ORAL; FEMALE; GENOTYPE; HUMANS; INDIA; MIDDLE AGED; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 58149400689     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.4905     Document Type: Article

References (41)

1. Parkin MD, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64.
3. Moore MA, Tajima K. Cervical cancer in the Asian pacific-epidemiology, screening and treatment. Asian Pac J Cancer Prev 2004; 5: 349-61.
4. Schoell WMJ, Janice KMF, Mirhashemi R. Epidemiology and biology of cervical cancer. Sem Surg Oncol 1999; 16: 203-11.
5. Settheetham-Ishida W, Singto Y, Yuenyao P, Tassaneeyakul W, Kanjanavirojkul N, Ishida T. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in northeastern Thailand. Cancer Lett 2004; 210: 205-11.
6. Sobti RC, Kaur S, Kaur P, Singh J, Gupta I, Jain V, Nakahara A. Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genet Cytogenet 2006; 166: 117-23.
7. Coker AL, Bond SM, William SA, Gerasimova T, Pirisi L. Active and passive smoking, high risk human papillomavirus and cervical neoplasia. Cancer Detect Prev 2002; 26: 121-8.
8. Tay SK, Tay KJ. Passive cigarette smoking is a risk factor in cervical neoplasia. Gynecol Oncol 2004; 93: 116-20.
9. Bertram CC. Evidence for practice: oral contraception and risk of cervical cancer. J Am Acad Nurse Pract 2004; 16: 455-61.
10. Matos A, Moutinho J, Pinto D, Medeiros R. The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. Eur J Cancer Prev 2005; 14: 485-91.
11. Castellsagué X, Muñoz N. Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; 31: 20-8.
12. Frazer IH. Immunology of papillomavirus infection. Curr Opin Immunol 1996; 8: 484-91.
13. Roh J, Kim M, Kim J, et al. Polymorphism in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett 2001; 165: 59-62.
14. Hajeer AH, Hutchinson IV. Influence of TNF-a gene polymorphisms on TNF-a production and disease. Hum Immunol 2001; 62: 1191-9.
15. Ghaderi M, Nikitina Zake L, Wallin K, et al. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 2001; 62: 1153-6.
16. Nanavaty U, Goldstein AD, Levin SJ. Polymorphisms in candidate asthma genes. Am J Med Sci 2001; 321: 11-6.
17. Lai HC, Sytwu HK, Sunc A, Yu MH, Yu CP, Liu HS. Single nucleotide polymorphism at Fas promoter is associated with cervical cancer. Int J Cancer 2003; 103: 221-5.
18. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001; 291; 1284-9.
19. Ford BN, Ruttan CC, Kyle VL, Brackley ME, Glickman BW. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis 2000; 21: 1977-81.
20. Mohrenweiser HW, Wilson DM 3rd, Jones IM. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 2003; 526: 93-125.
21. Lu J, Wei Q, Bondy ML, et al. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women ≤55 years. Carcinogenesis 2006; 27: 2209-16.
22. Kobayashi J, Antoccia A, Tauchi H, Matsuura S, Komatsu K. NBS1 and its functional role in the DNA damage response. DNA Repair (Amst) 2004; 3: 855-61.
23. Medina PP, Ahrendt SA, Pollan M, Fernandez P, Sidransky D, Sanchez-Cespedes M. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations. Cancer Epidemiol Biomarkers Prev 2003; 12: 699-704.
24. Hebbring SJ, Frederiksson H, White KA, et al. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 935-8.
25. Varon R, Reis A, Henze G, et al. Mutations in the NBS1 gene in childhood acute lymphoblastic leukemia (ALL). Cancer Res 2001; 61: 3570-2.
26. Roe BA, Crabtree JS, Khan AS. DNA isolation and sequencing. Essential technique series. New York: John Wiley and Sons, 1996.
27. Shen M, Lan Q, Zhang L, et al. Polymorphisms in genes involved in DNA double strand break repair pathway and susceptibility to benzene induced hepatotoxicity. Carcinogenis 2006; 27: 2083-9.
28. Stracker TH, Carson CT, Weitzman MD. Adenovirus oncoproteins inactivate the Mre 11-Rad50-NBS1 DNA repair complex. Nature 2002; 418: 348-52.
29. Hainaut P, Houstein M. P53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000; 77: 81-137.
30. David-Beabes GL, Lunn RM, London SJ. No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 911-12.
31. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002; 11: 1399-407.
32. Popanda O, Tan XL, Ambrosone CB, et al. Genetic polymorphisms in DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 2006; 15: 1048-50.
33. Forsti A, Angelini S, Festa F. Single nucleotide polymorphism in breast cancer. Oncol Rep 2004; 11: 917-22.
34. Lan Q, Shen M, Berndt SI, et al. Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer 2005; 49: 317-23.
35. Ryk C, Kumar R, Thirumaran RK, Hou SM. Polymorphisms in the DNA repair genes XRCCI, APEXI, XRCC3 and NBS1, and the risk for lung cancer in never and ever smokers. Lung Cancer 2006; 54: 285-92.
36. Somali S, Fabiola F, Shiferu S, et al. Polymorphism in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004; 25: 729-34.
37. Ryk C, Kumar R, Sanyal S, et al. Influence of polymorphism in DNA repair and defense genes on p53 mutation in bladder tumours. Cancer Lett 2005; 241: 142-9.
38. Matullo G, Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006; 27: 997-1007.
39. Varon R, Schoch C, Reis A, Hiddemann WC, Sperling K, Schnittger S. Mutation analysis of the NBSI gene in nineteen patients with acute myeloid leukemia with complex karyotype. Leuk Lymphoma 2003; 44: 1931-4.
40. Cerosaletti KM, Morrison VA, Sabath DE, Willerford DM, Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Gene Chromosomes Cancer 2002; 35: 282-6.
41. Plisiecka-Halasa J, Dansonka-Mieszkowska A, Rembiszewska A, Bidzinski M, Steffen J, Kupryjanczyk J. Nijmegen breakage syndrome gene 1 (NBS1) alternations and its protein (nibrin) expression in human ovarian tumours. Ann Hum Genet 2002; 66: 353-9.